UK biotech raises $1.5 billion in record quarter

摘要

Data from the Biolndustry Association (BIA) and Clarivate reveal that UK biotech companies raised more than ￡1 billion in equity finance between June and August 2020, the highest quarter for investments in the sector on record. The report states that $155 million was raised through the year's first initial public offering (IPO), showing continued US appetite for UK biotechs on NASDAQ, $367 million was raised through venture vapital (VC), including a return to pre-COVID-19 levels of seed and early stage VC deals, and $782 million was raised through other public financings on both the London and New York exchanges as biotech share prices continue to perform well on both sides of the Atlantic.